CoChat

HIV-1 uncoats in the nucleus near sites of integration

Open access

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Significance: For several decades, retroviral core uncoating has been thought to occur in the cytoplasm in coordination with reverse transcription, and while some recent studies have concluded that HIV-1 uncoating occurs at the nuclear envelope during nuclear import, none have concluded that uncoating occurs in the nucleus. Here, we developed methods to study HIV-1 uncoating by direct labeling and quantification of the viral capsid protein associated with infectious viral cores that produced transcriptionally active proviruses. We find that infectious viral cores in the nuclei of infected cells are largely intact and uncoat near their integration sites just before integration. These unexpected findings fundamentally change our understanding of HIV-1 postentry replication events.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1920631117

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. GFP-CA–labeled viral complexes uncoat in the nucleus within ∼1.5 µm of HIV-1 transcription sites. (A) HIV-1 vectors (Left) used to produce GFP-CA–labeled virions with high infectivity in HeLa, CEM-SS, and THP-1–derived macrophages (Right) compared to unlabeled control virions (set to 100%). (B) Nucleus of a HeLa cell infected with virions colabeled with GFP-CA + A3F-RRvT and immunostained with anti-Lamin A/C antibody (Left). Most nuclear A3F-RRvT viral complexes (∼70%) have detectable GFP-CA signals 6-h postinfection (hpi) compared to random locations in the nucleus (Right). (C) Representative live-cell microscopy images of a HeLa-Bgl cell infected with GFP-CA–labeled virions. A GFP-CA–labeled nuclear viral complex uncoated and lost the GFP-CA signal 7:10 hpi (I) and HIV-1 TS appeared near the site of GFP-CA disappearance 21:50 hpi (II). The HIV-1 TS appeared 1.2 µm from the GFP-CA signal (III). GFP reporter expression detected 25:30 hpi (IV). (D) Average normalized GFP-CA intensities are stable before abrupt GFP-CA loss within a single frame (<20 min). (E) Time between infection and nuclear GFP-CA loss, (F) nuclear GFP-CA loss and HIV-1 TS appearance, and (G) HIV-1 TS appearance and gfp reporter detection for 59 and 57 infectious GFP-CA–labeled viral complexes in HeLa-Bgl cells and HeLa-Bgl:Tat-Rev cells, respectively. (H) Distance between GFP-CA signal (time point prior to GFP-CA loss) and HIV-1 TS (first time point of detection) in HeLa-Bgl cells (∼8.4 h) and HeLa-Bgl:Tat-Rev cells (∼1.5 h) compared to HIV-1 TS movements in ∼1.5 h. (Scale bars, 5 µm; Inset, 2 µm.) For A and B, data are mean ± SD from three independent experiments; P values are from paired t tests. For (E–H), lines are mean ± SD; P values are from Welch’s t tests. ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant (P > 0.05).
Fig. 1. GFP-CA–labeled viral complexes uncoat in the nucleus within ∼1.5 µm of HIV-1 transcription sites. (A) HIV-1 vectors (Left) used to produce GFP-CA–labeled virions with high infectivity in HeLa, CEM-SS, and THP-1–derived macrophages (Right) compared to unlabeled control virions (set to 100%). (B) Nucleus of a HeLa cell infected with virions colabeled with GFP-CA + A3F-RRvT and immunostained with anti-Lamin A/C antibody (Left). Most nuclear A3F-RRvT viral complexes (∼70%) have detectable GFP-CA signals 6-h postinfection (hpi) compared to random locations in the nucleus (Right). (C) Representative live-cell microscopy images of a HeLa-Bgl cell infected with GFP-CA–labeled virions. A GFP-CA–labeled nuclear viral complex uncoated and lost the GFP-CA signal 7:10 hpi (I) and HIV-1 TS appeared near the site of GFP-CA disappearance 21:50 hpi (II). The HIV-1 TS appeared 1.2 µm from the GFP-CA signal (III). GFP reporter expression detected 25:30 hpi (IV). (D) Average normalized GFP-CA intensities are stable before abrupt GFP-CA loss within a single frame (<20 min). (E) Time between infection and nuclear GFP-CA loss, (F) nuclear GFP-CA loss and HIV-1 TS appearance, and (G) HIV-1 TS appearance and gfp reporter detection for 59 and 57 infectious GFP-CA–labeled viral complexes in HeLa-Bgl cells and HeLa-Bgl:Tat-Rev cells, respectively. (H) Distance between GFP-CA signal (time point prior to GFP-CA loss) and HIV-1 TS (first time point of detection) in HeLa-Bgl cells (∼8.4 h) and HeLa-Bgl:Tat-Rev cells (∼1.5 h) compared to HIV-1 TS movements in ∼1.5 h. (Scale bars, 5 µm; Inset, 2 µm.) For A and B, data are mean ± SD from three independent experiments; P values are from paired t tests. For (E–H), lines are mean ± SD; P values are from Welch’s t tests. ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant (P > 0.05).CC BY-NC-ND · PubMed Central
Fig. 2. Determination of the sensitivity of nuclear GFP-CA–labeled viral complexes to capsid, reverse transcriptase and integrase inhibitors. (A) Representative live-cell microscopy images of a nuclear GFP-CA–labeled viral complex before and after addition of PF74 (10 µM). Numbers in white indicate time (min) relative to the time of PF74 addition. (Scale bar, 5 µm; Inset, 2 µm.) (B) Time of disappearance of GFP-CA–labeled viral complexes in untreated control cells and PF74-treated cells during ∼1-h observation time. (C) Time-of-addition assays with NVP, PF74, or RAL. The numbers indicate the time at which 50% of the viral complexes became resistant to the inhibitors (infectivity T50). (D) Comparison of average infectivity T50 for NVP, PF74, and RAL from five independent experiments. (E) Proportion of nuclear GFP-CA–labeled complexes that disappeared during the observation time (21.6 hpi). (F) Average time of GFP-CA disappearance. Lines are mean ± SD; P values are from Welch’s t tests. (G) PF74 time-of-addition assays with GFP-CA–labeled and unlabeled virions. Comparison of average time at which 50% of the viral complexes became resistant to PF74 (infectivity T50) from four independent experiments (Right). (H) Comparison of the time of nuclear import previously determined for integrase-YFP- or A3F-YFP-labeled viral complexes (14) and GFP-CA–labeled viral complexes. For B and E, P values are from Fisher’s exact tests comparing the proportion nuclear GFP-CA complexes that disappeared. For D and G, lines are mean ± SD; P values are from paired t tests. ****P < 0.0001; ***P < 0.001; *P < 0.05; ns, not significant (P > 0.05).
Fig. 2. Determination of the sensitivity of nuclear GFP-CA–labeled viral complexes to capsid, reverse transcriptase and integrase inhibitors. (A) Representative live-cell microscopy images of a nuclear GFP-CA–labeled viral complex before and after addition of PF74 (10 µM). Numbers in white indicate time (min) relative to the time of PF74 addition. (Scale bar, 5 µm; Inset, 2 µm.) (B) Time of disappearance of GFP-CA–labeled viral complexes in untreated control cells and PF74-treated cells during ∼1-h observation time. (C) Time-of-addition assays with NVP, PF74, or RAL. The numbers indicate the time at which 50% of the viral complexes became resistant to the inhibitors (infectivity T50). (D) Comparison of average infectivity T50 for NVP, PF74, and RAL from five independent experiments. (E) Proportion of nuclear GFP-CA–labeled complexes that disappeared during the observation time (21.6 hpi). (F) Average time of GFP-CA disappearance. Lines are mean ± SD; P values are from Welch’s t tests. (G) PF74 time-of-addition assays with GFP-CA–labeled and unlabeled virions. Comparison of average time at which 50% of the viral complexes became resistant to PF74 (infectivity T50) from four independent experiments (Right). (H) Comparison of the time of nuclear import previously determined for integrase-YFP- or A3F-YFP-labeled viral complexes (14) and GFP-CA–labeled viral complexes. For B and E, P values are from Fisher’s exact tests comparing the proportion nuclear GFP-CA complexes that disappeared. For D and G, lines are mean ± SD; P values are from paired t tests. ****P < 0.0001; ***P < 0.001; *P < 0.05; ns, not significant (P > 0.05).CC BY-NC-ND · PubMed Central
Fig. 3. Nuclear viral complexes retain most of the GFP-CA associated with in vitro viral cores. (A) Live-cell microscopy images of a GFP-CA–labeled viral complex docked at the NE and in the nucleus after import. Numbers in white indicate time postinfection. (Scale bar, 2 µm.) (B) Normalized mean GFP-CA intensities of six frames before and after nuclear import indicate no significant loss of GFP-CA. (C) Comparison of the mean GFP-CA intensities (arbitrary units; a.u.) of intact virions, in vitro viral cores, and nuclear viral complexes in infected HeLa and CEM-SS T cells. Intact virions and in vitro viral cores with GFP-CA intensities below the detection limit (<265 a.u.) in HeLa and CEM-SS cell nuclei were removed. Lines are mean ± SD; P values are from Welch’s t tests. ****P < 0.0001; ns, not significant (P > 0.05). (D) Representative image of a GFP-CA–labeled nuclear complex in an infected CEM-SS T cell expressing mRuby-LaminB 6 hpi. (Scale bar, 5 µm.)
Fig. 3. Nuclear viral complexes retain most of the GFP-CA associated with in vitro viral cores. (A) Live-cell microscopy images of a GFP-CA–labeled viral complex docked at the NE and in the nucleus after import. Numbers in white indicate time postinfection. (Scale bar, 2 µm.) (B) Normalized mean GFP-CA intensities of six frames before and after nuclear import indicate no significant loss of GFP-CA. (C) Comparison of the mean GFP-CA intensities (arbitrary units; a.u.) of intact virions, in vitro viral cores, and nuclear viral complexes in infected HeLa and CEM-SS T cells. Intact virions and in vitro viral cores with GFP-CA intensities below the detection limit (<265 a.u.) in HeLa and CEM-SS cell nuclei were removed. Lines are mean ± SD; P values are from Welch’s t tests. ****P < 0.0001; ns, not significant (P > 0.05). (D) Representative image of a GFP-CA–labeled nuclear complex in an infected CEM-SS T cell expressing mRuby-LaminB 6 hpi. (Scale bar, 5 µm.)CC BY-NC-ND · PubMed Central
Fig. 4. CA-CPSF6 interaction at the NE facilitates nuclear import of viral complexes, the location of their uncoating, and the location of HIV-1 TS. (A) Representative live-cell microscopy images of a HeLa-Bgl cell infected with GFP-CA–labeled virions of CA mutant N74D. A GFP-CA–labeled viral complex uncoated at the edge of the nuclear Bgl-mCherry signal, 7:20 hpi (I) and HIV-1 TS appeared near the site of GFP-CA disappearance 13:40 hpi (II). The HIV-1 TS appeared 0.6 µm from the GFP-CA signal (III). GFP reporter expression detected 18:40 hpi (IV). (B) Time between infection and GFP-CA loss; data for WT the same as in Fig. 1E. Lines are mean ± SD; P values are from Welch’s t tests. (C) NE residence time of GFP-CA–labeled viral complexes prior to nuclear import. For N74D/A77V mutants, the time of nuclear import was assumed to occur at the time of GFP-CA loss (i.e., uncoating). (D) Cumulative frequency distribution of distances (µm) between HIV-1 TS and NE and random sites in the nuclei to NE; median distances are indicated by the red dotted line. P values are from Kolmogorov–Smirnov tests. **P < 0.01 compared to random; ****P < 0.0001 compared to random; ++++P < 0.0001 compared to WT. (E) N74D GFP-CA–labeled viral complexes localize to the NE but not in the nuclei of CEM-SS cells. (F) Quantitation of GFP-CA–labeled viral complexes at the NE and in the nucleus. Data are pooled from three independent infections (n = number of cells analyzed); P values are from paired t tests. ****P < 0.0001; ns, not significant (P > 0.05). (G) Representative live-cell microscopy images of infected HeLa:mRuby-CPSF6 cells show mRuby-CPSF6 recruitment to a GFP-CA–labeled viral complex located at or near the NE (I and II); dual-labeled GFP-CA and mRuby-CPSF6 complexes are imported into the nucleus (III). (H) Time between NE docking to CPSF6 detection and CPSF6 detection to nuclear import for 18 GFP-CA–labeled viral complexes. Lines are mean ± SD (I) Proportion of NE-associated GFP-CA+ viral complexes that are CPSF6+. The viral complexes that entered the nucleus during the observation time and those that were docked at the NE but failed to enter the nucleus were analyzed. (J) Simultaneous disappearance of intranuclear GFP-CA and mRuby-CPSF6 signals. (Scale bars, 5 µm; Inset, 2 µm.)
Fig. 4. CA-CPSF6 interaction at the NE facilitates nuclear import of viral complexes, the location of their uncoating, and the location of HIV-1 TS. (A) Representative live-cell microscopy images of a HeLa-Bgl cell infected with GFP-CA–labeled virions of CA mutant N74D. A GFP-CA–labeled viral complex uncoated at the edge of the nuclear Bgl-mCherry signal, 7:20 hpi (I) and HIV-1 TS appeared near the site of GFP-CA disappearance 13:40 hpi (II). The HIV-1 TS appeared 0.6 µm from the GFP-CA signal (III). GFP reporter expression detected 18:40 hpi (IV). (B) Time between infection and GFP-CA loss; data for WT the same as in Fig. 1E. Lines are mean ± SD; P values are from Welch’s t tests. (C) NE residence time of GFP-CA–labeled viral complexes prior to nuclear import. For N74D/A77V mutants, the time of nuclear import was assumed to occur at the time of GFP-CA loss (i.e., uncoating). (D) Cumulative frequency distribution of distances (µm) between HIV-1 TS and NE and random sites in the nuclei to NE; median distances are indicated by the red dotted line. P values are from Kolmogorov–Smirnov tests. **P < 0.01 compared to random; ****P < 0.0001 compared to random; ++++P < 0.0001 compared to WT. (E) N74D GFP-CA–labeled viral complexes localize to the NE but not in the nuclei of CEM-SS cells. (F) Quantitation of GFP-CA–labeled viral complexes at the NE and in the nucleus. Data are pooled from three independent infections (n = number of cells analyzed); P values are from paired t tests. ****P < 0.0001; ns, not significant (P > 0.05). (G) Representative live-cell microscopy images of infected HeLa:mRuby-CPSF6 cells show mRuby-CPSF6 recruitment to a GFP-CA–labeled viral complex located at or near the NE (I and II); dual-labeled GFP-CA and mRuby-CPSF6 complexes are imported into the nucleus (III). (H) Time between NE docking to CPSF6 detection and CPSF6 detection to nuclear import for 18 GFP-CA–labeled viral complexes. Lines are mean ± SD (I) Proportion of NE-associated GFP-CA+ viral complexes that are CPSF6+. The viral complexes that entered the nucleus during the observation time and those that were docked at the NE but failed to enter the nucleus were analyzed. (J) Simultaneous disappearance of intranuclear GFP-CA and mRuby-CPSF6 signals. (Scale bars, 5 µm; Inset, 2 µm.)CC BY-NC-ND · PubMed Central
Fig. 5. Model for nuclear import and uncoating of HIV-1. WT and N74D/A77V viral cores dock at the NE. CPSF6 is recruited to the WT viral cores at the NE but not to the N74D/A77V viral cores. WT viral cores are imported into the nucleus ∼1.9 h after docking at the NE; the N74D/A77V GFP-CA–labeled viral cores remain associated with the NE and are not imported into the nucleus. Reverse transcription is completed inside the intact (or nearly intact) viral core for WT (in the nucleus) and N74D/A77V mutants (at NE). The nuclear WT viral complexes and NE-associated N74D/A77V viral complexes uncoat ∼10 h after infection. WT PIC integrates into chromatin near the sites of uncoating ∼1.5 µm from the NE; the N74D/A77V PIC integrates into chromatin associated with lamina-associated domains (LADs) ∼0.7 to 0.8 µm from the NE. In addition to the localization of transcriptionally active WT and N74D/A77V proviruses to the nuclear periphery in these studies, localization of WT viral DNA (50, 51) and N74D/A77V DNA (23, 25) to the nuclear periphery was previously reported.
Fig. 5. Model for nuclear import and uncoating of HIV-1. WT and N74D/A77V viral cores dock at the NE. CPSF6 is recruited to the WT viral cores at the NE but not to the N74D/A77V viral cores. WT viral cores are imported into the nucleus ∼1.9 h after docking at the NE; the N74D/A77V GFP-CA–labeled viral cores remain associated with the NE and are not imported into the nucleus. Reverse transcription is completed inside the intact (or nearly intact) viral core for WT (in the nucleus) and N74D/A77V mutants (at NE). The nuclear WT viral complexes and NE-associated N74D/A77V viral complexes uncoat ∼10 h after infection. WT PIC integrates into chromatin near the sites of uncoating ∼1.5 µm from the NE; the N74D/A77V PIC integrates into chromatin associated with lamina-associated domains (LADs) ∼0.7 to 0.8 µm from the NE. In addition to the localization of transcriptionally active WT and N74D/A77V proviruses to the nuclear periphery in these studies, localization of WT viral DNA (50, 51) and N74D/A77V DNA (23, 25) to the nuclear periphery was previously reported.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 1

  1. 10.1128/mcb.11.3.1419-1430.1991 · doi:10.1128/mcb.11.3.1419-1430.1991 · Paper page

Cited by

See all 317

Metadata

Authors
Burdick, R. C., Li, C., Munshi, M., Rawson, J. M. O., Nagashima, K., Hu, W.-S., & Pathak, V. K.
Affiliations
Frederick National Laboratory for Cancer Research (US)
Corresponding author
Pathak, Vinay K.
Venue
Proceedings of the National Academy of Sciences
Published
2020-02-24
Volume
117
Issue
10
Pages
5486-5493
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W3007556991
Cited by
313
References
68
Citations by year
2026: 30 · 2025: 47 · 2024: 55 · 2023: 32 · 2022: 49 · 2021: 63 · 2020: 36
FWCI
23.98
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
HHS | NIH | National Cancer Institute (Intramural, HHSN26120080001E)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV-1, capsid uncoating, nuclear import, viral DNA integration, capsid protein, CPSF6, reverse transcription, nuclear pores, innate immune evasion
MeSH terms
Cell Nucleus, Humans, Virus Replication, HIV-1, HIV Infections, Virus Integration, Active Transport, Cell Nucleus, Nuclear Pore, Capsid Proteins, mRNA Cleavage and Polyadenylation Factors, Green Fluorescent Proteins, Virus Uncoating, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIV-1 uncoats in the nucleus near sites of integration. https://app.cochat.ai/papers/10.1073/pnas.1920631117
The paper
Burdick, R. C., Li, C., Munshi, M., Rawson, J. M. O., Nagashima, K., Hu, W.-S., & Pathak, V. K. (2020). HIV-1 uncoats in the nucleus near sites of integration. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1920631117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.